UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome

Arthritis & rheumatology (Hoboken, N.J.), 2017-07, Vol.69 (7), p.1440-1450

2017

Volltextzugriff (PDF)

EP04 Hypercalcaemia of sarcoidosis in a patient with severe renal impairment successfully treated with denosumab

Rheumatology (Oxford, England), 2020-04, Vol.59 (Supplement_2)

2020

Volltextzugriff (PDF)

002. BREAKING BAD IN SUBURBIA: A CASE OF DRUG-INDUCED VASCULITIS

Rheumatology (Oxford, England), 2017-04, Vol.56 (suppl_2)

2017

Volltextzugriff (PDF)

006. LARGE VESSEL INVOLVEMENT IN ANTI_NEUTROPHIL CYTOPLASMIC ANTIBODY–POSITIVE VASCULITIS

Rheumatology (Oxford, England), 2017-04, Vol.56 (suppl_2)

2017

Volltextzugriff (PDF)

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

Nature medicine, 2022-06, Vol.28 (6), p.1256-1268

2022

Volltextzugriff (PDF)

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

The Lancet (British edition), 2021-01, Vol.397 (10271), p.305-317

2021

Volltextzugriff (PDF)

OA14 A case of scleromyxedema with muscle involvement including myotonia and dysphagia

Rheumatology advances in practice, 2022-09, Vol.6 (Supplement_1)

2022

Volltextzugriff (PDF)

Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica

Arthritis and rheumatism, 2007-06, Vol.57 (5), p.803-809

2007

Volltextzugriff (PDF)

39. Sclerotic bone lesions: a diagnostic dilemma

Rheumatology advances in practice, 2018-09, Vol.2 (suppl_1)

2018

Volltextzugriff (PDF)

B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: Relationship to Disease Stages and Drug Exposure

Arthritis & rheumatology (Hoboken, N.J.), 2020-05, Vol.72 (5), p.714-725

2020

Volltextzugriff (PDF)

VASCULITISE77. ANTI–NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS QUALITY IMPROVEMENT PROJECT: ARE WE MEETING BRITISH SOCIETY FOR RHEUMATOLOGY GUIDELINES?

Rheumatology (Oxford, England), 2017-04, Vol.56 (suppl_2)

2017

Volltextzugriff (PDF)

MUSCLE DISORDERSE34. A CASE OF PARANEOPLASTIC DERMATOMYOSITIS

Rheumatology (Oxford, England), 2017-04, Vol.56 (suppl_2)

2017

Volltextzugriff (PDF)

Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register

Rheumatology (Oxford, England), 2018-03, Vol.57 (3), p.470-479

2018

Volltextzugriff (PDF)

Health-related utility values of patients with primary Sjögren's syndrome and its predictors

Annals of the rheumatic diseases, 2014-07, Vol.73 (7), p.1362-1368

2014

Volltextzugriff (PDF)

Case Reports [3–24]

Rheumatology (Oxford, England), 2010-04, Vol.49 (suppl-1), p.i35-i43

2010

Volltextzugriff (PDF)

Septic discitis as a complication of infective endocarditis caused by Streptococcus oralis

Journal of rheumatology, 2003-03, Vol.30 (3), p.632

2003

Volltextzugriff (PDF)

Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil

Arthritis research & therapy, 2023-06, Vol.25 (1), p.111-111, Article 111

2023

Volltextzugriff (PDF)

125. Audit on Gout Management: Adhering to the BSR Guidelines

Rheumatology (Oxford, England), 2014-04, Vol.53 (suppl_1), p.i107-i107

2014

Volltextzugriff (PDF)

O07 Randomised, open labelled clinical trial to investigate synovial mechanisms determining response: resistance to rituximab versus tocilizumab in RA patients failing TNF inhibitor therapy

Rheumatology (Oxford, England), 2020-04, Vol.59 (Supplement_2)

2020

Volltextzugriff (PDF)

Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients

Rheumatology (Oxford, England), 2011-01, Vol.50 (1), p.189-195

2011

Volltextzugriff (PDF)

Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?

Rheumatology (Oxford, England), 2015-04, Vol.54 (4), p.655-659

2015

Volltextzugriff (PDF)

United Kingdom Primary Sjogren's Syndrome Registry--a united effort to tackle an orphan rheumatic disease

Rheumatology (Oxford, England), 2011-01, Vol.50 (1), p.32-39

2011

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Randomized Controlled Trial of Rituximab and Cost‐Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome

Effect of rituximab on a salivary gland ultrasound score in primary Sjögren's syndrome: results of the TRACTISS randomised double-blind multicentre substudy

EP04 Hypercalcaemia of sarcoidosis in a patient with severe renal impairment successfully treated with denosumab

Comparison of ESSDAI and ClinESSDAI in potential optimisation of trial outcomes in primary Sjögren's syndrome: examination of data from the UK Primary Sjögren's Syndrome Registry

002. BREAKING BAD IN SUBURBIA: A CASE OF DRUG-INDUCED VASCULITIS

006. LARGE VESSEL INVOLVEMENT IN ANTI_NEUTROPHIL CYTOPLASMIC ANTIBODY–POSITIVE VASCULITIS

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

OA14 A case of scleromyxedema with muscle involvement including myotonia and dysphagia

Clinical outcomes, quality of life, and diagnostic uncertainty in the first year of polymyalgia rheumatica

39. Sclerotic bone lesions: a diagnostic dilemma

B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: Relationship to Disease Stages and Drug Exposure

VASCULITISE77. ANTI–NEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIS QUALITY IMPROVEMENT PROJECT: ARE WE MEETING BRITISH SOCIETY FOR RHEUMATOLOGY GUIDELINES?

MUSCLE DISORDERSE34. A CASE OF PARANEOPLASTIC DERMATOMYOSITIS

Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results from the British Isles Lupus Assessment Group Biologics Register

Health-related utility values of patients with primary Sjögren's syndrome and its predictors

Case Reports [3–24]

Septic discitis as a complication of infective endocarditis caused by Streptococcus oralis

Deconvolution of whole blood transcriptomics identifies changes in immune cell composition in patients with systemic lupus erythematosus (SLE) treated with mycophenolate mofetil

125. Audit on Gout Management: Adhering to the BSR Guidelines

A Transcriptional Signature of Fatigue Derived from Patients with Primary Sjögren's Syndrome

O07 Randomised, open labelled clinical trial to investigate synovial mechanisms determining response: resistance to rituximab versus tocilizumab in RA patients failing TNF inhibitor therapy

Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients

Do the EULAR Sjögren's syndrome outcome measures correlate with health status in primary Sjögren's syndrome?

United Kingdom Primary Sjogren's Syndrome Registry--a united effort to tackle an orphan rheumatic disease

Suchergebnisse filtern